Nektar Therapeutics (NKTR)

02:26 AM

How robust is Nektar Therapeutics (ITH0) stock financial position2025 Institutional Moves & Free Daily Entry Point Trade Alerts - Newser

02:26 AM

02:10 AM

Is Nektar Therapeutics stock attractive for ETFs2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser

02:10 AM

01:39 AM

How strong dollar benefits Nektar Therapeutics (ITH0) stockTrade Signal Summary & Free Real-Time Market Sentiment Alerts - Newser

01:39 AM

Dec 02, 2025

Will Nektar Therapeutics stock benefit from upcoming earnings reportsBreakout Watch & Low Drawdown Momentum Ideas - Newser

Dec 02, 2025

Dec 02, 2025

Colorectal Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | Takeda, Genentech/Seagen, AstraZeneca and Daiichi Sankyo, Merck, Amgen, Daiichi Sankyo Company, Mirati Therapeu - Barchart.com

Dec 02, 2025

Dec 02, 2025

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors - The Manila Times

Dec 02, 2025

Dec 02, 2025

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors - GlobeNewswire Inc.

Dec 02, 2025

Dec 02, 2025

Latex Allergy Market Covering Prime Factors and Competitive - openPR.com

Dec 02, 2025

Dec 01, 2025

Wall Street Analysts Believe Nektar (NKTR) Could Rally 64.53%: Here's is How to Trade - Finviz

Dec 01, 2025

Nov 29, 2025

Nektar Therapeutics Reveals Promising Phase 2b Trial Results - MSN

Nov 29, 2025

Nov 26, 2025

Nektar Therapeutics Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt

Nov 26, 2025

Nov 26, 2025

Jefferies Maintains Nektar Therapeutics (NKTR) Buy Recommendation - Nasdaq

Nov 26, 2025

Nov 26, 2025

Citigroup Initiates Coverage on NKTR with 'Buy' Rating | NKTR St - GuruFocus

Nov 26, 2025

Nov 26, 2025

Jefferies Raises Nektar Therapeutics (NKTR) Price Target to $121 - GuruFocus

Nov 26, 2025

Nov 26, 2025

Nektar Therapeutics R (ITH0.MU) Q2 FY2025 earnings call transcript - Yahoo Finance

Nov 26, 2025

Nov 26, 2025

Nektar Therapeutics CEO sells $119,795 in shares By Investing.com - Investing.com South Africa

Nov 26, 2025

Nov 26, 2025

Citi starts Nektar with Buy, opens ‘positive catalyst watch’ - TipRanks

Nov 26, 2025

Nov 26, 2025

Nektar (NKTR) Receives Buy Rating with Positive Outlook from Cit - GuruFocus

Nov 26, 2025

Nov 26, 2025

Citi Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $102 - 富途牛牛

Nov 26, 2025

Nov 26, 2025

Nektar Therapeutics chief R&D officer sells $62,801 in stock By Investing.com - Investing.com Australia

Nov 26, 2025

Nov 25, 2025

Nektar Therapeutics CLO Wilson sells $34,196 in shares By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 25, 2025

Nektar Therapeutics Announces Pricing of $100 Million Public Offering (PR Newswire) - Aktiellt

Nov 25, 2025

Nov 25, 2025

Nektar Therapeutics chief R&D officer sells $62,801 in stock - Investing.com

Nov 25, 2025

Nov 25, 2025

Nektar Therapeutics CLO Wilson sells $34,196 in shares - Investing.com

Nov 25, 2025

Nov 25, 2025

How Investors May Respond To Nektar Therapeutics (NKTR) Clinical Progress and Leadership Transition - simplywall.st

Nov 25, 2025

Nov 25, 2025

Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $105 - 富途牛牛

Nov 25, 2025

Nov 24, 2025

Nektar Therapeutics stock price target raised to $121 from $99 at Jefferies - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

Nektar Therapeutics (NKTR) PT Raised to $121 at Jefferies - StreetInsider

Nov 24, 2025

Nov 24, 2025

Assessing Nektar Therapeutics (NKTR) Valuation Following Recent Share Price Surge - simplywall.st

Nov 24, 2025

Nov 23, 2025

Nektar Therapeutics Stock Analysis and ForecastInsider Buying Signals & Stay One Step Ahead of Risk Events - earlytimes.in

Nov 23, 2025

Nov 23, 2025

Is Nektar Therapeutics (NKTR) The Hottest SMID-Cap Stock to Buy Now? - Finviz

Nov 23, 2025

Nov 21, 2025

Nektar Therapeutics announces chief legal officer transition effective year-end By Investing.com - Investing.com India

Nov 21, 2025

Nov 21, 2025

Nektar Therapeutics Announces Chief Legal Officer Departure - TipRanks

Nov 21, 2025

Nov 21, 2025

Nektar Therapeutics announces chief legal officer transition effective year-end - Investing.com

Nov 21, 2025

Nov 21, 2025

Nektar Therapeutics Announces Chief Legal Officer Change - TradingView

Nov 21, 2025

Nov 21, 2025

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma - HCPLive

Nov 21, 2025

Nov 21, 2025

Can Nektar Therapeutics (ITH0) stock stage a strong rebound this quarterMarket Risk Summary & Daily Market Momentum Tracking - newser.com

Nov 21, 2025

Nov 21, 2025

Will Nektar Therapeutics (ITH0) stock beat Nasdaq index returns2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com

Nov 21, 2025

Nov 20, 2025

Nektar at Jefferies: Biologics in Focus for New Indications By Investing.com - Investing.com Australia

Nov 20, 2025

Nov 20, 2025

Nektar at Jefferies: Biologics in Focus for New Indications - Investing.com

Nov 20, 2025

Nov 20, 2025

Nektar Therapeutics (NKTR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 20, 2025

Nov 20, 2025

How big funds are accumulating Nektar Therapeutics (ITH0) stockMarket Rally & Long-Term Safe Investment Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Will Nektar Therapeutics (ITH0) stock profit from fiscal stimulusWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com

Nov 20, 2025

Nov 20, 2025

Is Nektar Therapeutics stock attractive for passive investorsJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - newser.com

Nov 20, 2025

Nov 20, 2025

How Nektar Therapeutics (ITH0) stock trades in high volatilityMarket Risk Analysis & Safe Entry Zone Tips - newser.com

Nov 20, 2025

Nov 20, 2025

What RSI levels show for Nektar Therapeutics (ITH0) stock2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com

Nov 20, 2025

Nov 20, 2025

Is it time to cut losses on Nektar TherapeuticsJuly 2025 Highlights & Verified Entry Point Signals - newser.com

Nov 20, 2025